We recently compiled a list of the 10 Firms Lead Thursday’s Rally on Better Earnings, Bargain-Hunting. In this article, we ...

After parting ways with BeiGene in 2023, Novartis effectively bowed out of the PD-1 race. | The rising class of bispecifics ...

Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from ...

ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to advance Anktiva in non-small cell lung cancer.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Dubai, UAE: MSD, a leading biopharmaceutical company, has established a new office in Dubai, further solidifying its ...

Daniel Vitt, CEO, Immunic Therapeutics, discusses promising results from the Phase Ib trial of IMU-856 in celiac disease.

As January 2025 draws to a close, U.S. stock markets have shown resilience, with major indices like the Dow Jones Industrial Average and S&P 500 closing higher amid a wave of earnings reports and ...

As the U.S. stock market shows signs of resilience with major indexes poised for gains following favorable inflation data, investors are keenly observing opportunities amid fluctuating corporate ...